$8.26
0.000.00%
Pre-Market: Jan 17, 4:00 PM EDT
Comments
Loading...
Amneal Pharmaceuticals (NASDAQ:AMRX) Stock, Earnings Estimates, EPS, And Revenue
Amneal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 28
EPS Estimate
$0.150
Quarterly Revenue Estimate
$700.83M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$2.68B
Analyze the earnings history of Amneal Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Amneal Pharmaceuticals (AMRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-08 | $0.16 | $0.13 | 23.1 % |
| Q2 | 2024-08-09 | $0.16 | $0.14 | 14.3 % |
| Q1 | 2024-05-03 | $0.14 | $0.09 | 55.6 % |
| Q4 | 2024-03-01 | $0.14 | $0.09 | 55.6 % |
Amneal Pharmaceuticals (AMRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-08 | $702.47M | $696.80M | 0.81 % |
| Q2 | 2024-08-09 | $701.78M | $658.14M | 6.63 % |
| Q1 | 2024-05-03 | $659.19M | $619.03M | 6.49 % |
| Q4 | 2024-03-01 | $616.98M | $634.23M | -2.72 % |
FAQ
When is Amneal Pharmaceuticals (NASDAQ:AMRX) reporting earnings?
Amneal Pharmaceuticals (AMRX) is scheduled to report earnings on February 28, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
What were the latest earnings per share (EPS) for Amneal Pharmaceuticals (NASDAQ:AMRX)?
The Actual EPS was $0.16, which beat the estimate of $0.13.
What were Amneal Pharmaceuticals’s (NASDAQ:AMRX) revenues?
The Actual Revenue was $702.5M, which beat the estimate of $696.8M.
Browse earnings estimates, EPS, and revenue on all stocks.